Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q1 FY25 results · Apr–Jun 2024
Camlin Fine Sciences reported revenue from operations of ₹395.85 crore (down 5.7% from Q1 FY24) and net loss of ₹34.65 crore for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 395.85 | 419.60 | −5.7% | 401.69 | −1.5% |
| Other income | 1.87 | 6.37 | −70.7% | 5.76 | −67.6% |
| Total income | 397.72 | 425.97 | −6.6% | 407.46 | −2.4% |
| Profit before tax | (23.48) | 16.08 | Turned loss | (93.51) | Loss narrowed |
| Net profit for the period | (34.65) | 12.02 | Turned loss | (81.79) | Loss narrowed |
| Attributable to shareholders of the company | (33.95) | 15.55 | Turned loss | (77.14) | Loss narrowed |
| EPS, basic (₹) | (2.03) | 0.96 | Turned loss | (4.64) | Loss narrowed |
| Net margin (%) | -8.8 | 2.9 | -20.4 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 181.91 | 161.11 | +12.9% | 220.33 | −17.4% |
| Other income | 1.78 | 6.01 | −70.4% | 5.55 | −67.9% |
| Total income | 183.69 | 167.12 | +9.9% | 225.88 | −18.7% |
| Profit before tax | (17.60) | 7.26 | Turned loss | (48.68) | Loss narrowed |
| Net profit for the period | (13.68) | 5.78 | Turned loss | (44.07) | Loss narrowed |
| EPS, basic (₹) | (0.82) | 0.36 | Turned loss | (2.65) | Loss narrowed |
| Net margin (%) | -7.5 | 3.6 | -20.0 |
Consolidated
- Filed with BSE
- 24 Aug 2024, 14:49 IST
- Board meeting
- 12 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 Aug 2024, 14:49 IST
- Board meeting
- 12 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE